Indeed, STING knockout (KO) mice (i.e. Tmem173–/–) exhibit defective tumor control in some murine tumor models and demonstrate a significantly reduced therapeutic response to immune checkpoint blockade (ICB) therapy relative to wildtype mice (14). Here, STING1 is linked to neoplasm.